# A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

> **NCT05429320** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 37 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Metastatic Non Small Cell Lung Cancer
- Nsclc
- NSCLC Stage IV
- Minimal Residual Disease
- Non Small Cell Lung Cancer Metastatic

## Interventions

- **PROCEDURE:** Local ablative therapy
- **OTHER:** Blood collection to assess for ctDNA

## Key facts

- **NCT ID:** NCT05429320
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-15
- **Primary completion:** 2026-01-28
- **Final completion:** 2026-01-28
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429320, "A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05429320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*